Among the 99 malignant neoplasms, only 19 (19/99; 19.2%) showed a complete loss of EPCAM expression (Figure 1), and 10 (10/99; 10.1%) were informative and corresponded to CRC, all belonging to patients with EPCAM 3′-end deletions. Here, EPCAM is linked to colorectal carcinoma.